Sinopharm Group Co. Ltd.'s (HKG:1099) Low P/E No Reason For Excitement
Feb 16
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Healthcare Services Industry Analysis
UpdatedFeb 24, 2026
DataAggregated Company Financials
Companies59
- 7D2.0%
- 3M-3.6%
- 1Y-17.4%
- YTD7.0%
Guanze Medical Information Industry (Holding) is up 37%, leading the way for the Healthcare Services industry, which has gained 2.0%. In the same time, Gushengtang Holdings was down 6.7%. In the past year, the industry is down 17%. Looking forward, earnings are forecast to grow by 21% annually.
Industry Valuation and Performance
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 25 Feb 2026 | HK$165.3b | HK$766.8b | HK$9.3b | 11.3x | 17.7x | 0.2x |
| Fri, 23 Jan 2026 | HK$160.2b | HK$757.3b | HK$9.2b | 12x | 17.4x | 0.2x |
| Sun, 21 Dec 2025 | HK$156.4b | HK$745.9b | HK$9.0b | 11.7x | 17.4x | 0.2x |
| Tue, 18 Nov 2025 | HK$178.4b | HK$738.3b | HK$8.9b | 12.8x | 20x | 0.2x |
| Thu, 16 Oct 2025 | HK$179.7b | HK$738.6b | HK$8.3b | 12.8x | 21.8x | 0.2x |
| Sat, 13 Sep 2025 | HK$232.0b | HK$823.2b | HK$11.5b | 13.3x | 20.3x | 0.3x |
| Mon, 11 Aug 2025 | HK$228.1b | HK$825.9b | HK$13.0b | 13.9x | 17.5x | 0.3x |
| Wed, 09 Jul 2025 | HK$213.4b | HK$827.3b | HK$13.0b | 13.1x | 16.5x | 0.3x |
| Fri, 06 Jun 2025 | HK$235.2b | HK$810.0b | HK$10.8b | 12.1x | 21.8x | 0.3x |
| Sun, 04 May 2025 | HK$209.0b | HK$790.5b | HK$10.3b | 11x | 20.3x | 0.3x |
| Tue, 01 Apr 2025 | HK$210.0b | HK$802.2b | HK$10.9b | 11.9x | 19.2x | 0.3x |
| Thu, 27 Feb 2025 | HK$208.6b | HK$809.0b | HK$14.6b | 12.5x | 14.3x | 0.3x |
| Sat, 25 Jan 2025 | HK$197.3b | HK$812.1b | HK$14.6b | 12.7x | 13.5x | 0.2x |
| Mon, 23 Dec 2024 | HK$222.9b | HK$805.1b | HK$14.5b | 12x | 15.4x | 0.3x |
| Wed, 20 Nov 2024 | HK$219.5b | HK$812.2b | HK$14.6b | 13.1x | 15x | 0.3x |
| Fri, 18 Oct 2024 | HK$213.9b | HK$824.7b | HK$15.2b | 13.2x | 14.1x | 0.3x |
| Sun, 15 Sep 2024 | HK$190.9b | HK$837.9b | HK$15.6b | 13.1x | 12.2x | 0.2x |
| Tue, 13 Aug 2024 | HK$231.9b | HK$827.1b | HK$12.6b | 10.7x | 18.3x | 0.3x |
| Thu, 11 Jul 2024 | HK$240.3b | HK$817.7b | HK$12.5b | 10.7x | 19.3x | 0.3x |
| Sat, 08 Jun 2024 | HK$264.6b | HK$821.7b | HK$12.5b | 12.3x | 21.1x | 0.3x |
| Mon, 06 May 2024 | HK$255.9b | HK$822.5b | HK$12.5b | 12.1x | 20.4x | 0.3x |
| Wed, 03 Apr 2024 | HK$225.8b | HK$821.2b | HK$12.7b | 11.6x | 17.8x | 0.3x |
| Fri, 01 Mar 2024 | HK$247.0b | HK$814.9b | HK$11.8b | 14.3x | 21x | 0.3x |
| Sun, 28 Jan 2024 | HK$233.6b | HK$819.9b | HK$12.1b | 14.8x | 19.4x | 0.3x |
| Tue, 26 Dec 2023 | HK$235.2b | HK$820.2b | HK$12.5b | 15.1x | 18.9x | 0.3x |
| Thu, 23 Nov 2023 | HK$259.3b | HK$817.0b | HK$12.3b | 16x | 21.1x | 0.3x |
| Sat, 21 Oct 2023 | HK$268.4b | HK$801.3b | HK$12.3b | 13.2x | 21.9x | 0.3x |
| Mon, 18 Sep 2023 | HK$286.0b | HK$806.7b | HK$12.7b | 13.2x | 22.4x | 0.4x |
| Wed, 16 Aug 2023 | HK$285.8b | HK$775.0b | HK$11.3b | 10.6x | 25.3x | 0.4x |
| Fri, 14 Jul 2023 | HK$327.0b | HK$809.1b | -HK$57,853,067.00 | 10.9x | -5653x | 0.4x |
| Sun, 11 Jun 2023 | HK$315.3b | HK$775.3b | HK$684.9m | 13.2x | 460.4x | 0.4x |
| Tue, 09 May 2023 | HK$336.0b | HK$798.7b | HK$1.3b | 11.2x | 263x | 0.4x |
| Thu, 06 Apr 2023 | HK$334.1b | HK$799.8b | HK$1.6b | 16.6x | 207.4x | 0.4x |
| Sat, 04 Mar 2023 | HK$325.7b | HK$782.5b | HK$3.5b | 16.5x | 92.7x | 0.4x |
Price to Earnings Ratio
92.7x
Current Industry PE
- Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 17.7x which is higher than its 3-year average PE of -40.1x.
- The industry is trading close to its 3-year average PS ratio of 0.30x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 38% per year over the last three years, while revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.78% | |
| Healthcare | 1.74% | |
| Healthcare Services | 1.96% | |
| Healthcare Services | 3.06% | |
| Healthcare Distributors | 1.99% | |
| Healthcare Facilities | 0.33% | |
| Managed Healthcare | 0% | 0 |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 41.2%, which is higher than its past year's earnings growth of 5.9% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 12.3x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 41% over the next 5 years.
- This is better than its past earnings growth rate of 5.9% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 12% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2427 Guanze Medical Information Industry (Holding) | HK$4.09 | 36.8% +HK$1.0b | 1,036.1% | PE164.8x | |
| 1099 Sinopharm Group | HK$21.80 | 1.5% +HK$998.6m | 9.8% | PE8.5x | |
| 2656 160 Health International | HK$63.45 | 3.7% +HK$757.0m | n/a | PS29.5x | |
| 8037 China Biotech Services Holdings | HK$0.85 | 10.4% +HK$428.7m | 102.4% | PS15.3x | |
| 648 SoftMedx Healthcare | HK$0.28 | 51.4% +HK$202.0m | n/a | PE1.8x |
